MITA News
-
MITA Statement
Washington, D.C. – David Fisher, Vice President for Healthcare Policy and Strategy at Siemens Healthcare, testified on behalf of the Medical Imaging & Technology Alliance (MITA) today at the Internal Revenue Service (IRS) Hearing on Proposed Medical Device Excise Tax Regulations [REG-113770-10] to voice the industry’s concerns about implementation of the tax imposed by the Affordable Care Act. MITA has submitted comments to the IRS on the proposed regulations, slated to go into effect in 2013, requesting clarification surrounding how and when the new tax will be put into practice.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today said that the assertion in a recent comment letter filed with the IRS that the U.S. excise tax on medical devices would provide a “windfall” for medical device companies is inaccurate and misunderstands the operation of excise taxes.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today commended the U.S. House Committee on Energy & Commerce efforts to solidify the third Medical Device User Fee Agreement (MDUFA III) in their mark-up of the Food and Drug Administration (FDA) Safety and Innovation Act. The reauthorization of the medical device user fee program will result in bringing more devices to market in a timely manner, increasing the number of products in development and fostering heightened competition on a global scale.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today applauded bipartisan efforts by the Senate Committee on Energy and Natural Resources to safeguard access to helium, a critical element used in Magnetic Resonance Imaging (MRI) technology, with the Helium Stewardship Act of 2012 (S.2374). In a testimony before the Senate Committee on Energy and Natural Resources today, Tom Rauch, Global Sourcing Manager, Servicing and Aftermarket Solutions for member company GE Healthcare, endorsed the legislation, which lays out a responsible resource management strategy for the Federal Helium Reserve, and called for its swift passage in order to secure long-term access to nearly one third of the world’s helium supply.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) issued the following statement today regarding the release of new draft guidance from the U.S. Food and Drug Administration (FDA) on pediatric safety considerations for the design of new medical imaging devices, including computed tomography (CT), fluoroscopy, and traditional X-ray
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today applauded bipartisan efforts by the Senate Committee on Energy and Natural Resources to safeguard access to helium with the Helium Stewardship Act of 2012 (S-2374).
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today commended the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee’s efforts to solidify the third Medical Device User Fee Agreement (MDUFA III) in their mark-up of the Food and Drug Administration (FDA) Safety and Innovation Act. The reauthorization of the medical device user fee program will foster the development of innovative, life-saving technologies, while also expanding patient access to the next generation of diagnostics, treatments, and cures.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today commended the Patient Advocate Foundation (PAF) for its new report detailing the impact of health coverage denials on patients seeking medical imaging exams. The internal case management data released by PAF show that denials to patients seeking critical imaging services by their insurance providers have doubled over the last four years. Of equal concern, 90 percent of the reversed denials for imaging services were actually covered by those health plans.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) met with international leaders on Wednesday at the U.S.-China Joint Commission on Commerce and Trade (JCCT) Pharmaceuticals and Medical Devices Subgroup annual meeting to promote increased collaboration and access to life-saving medical imaging technology. Following MITA’s presentation to the Chinese State Food and Drug administration (SFDA), subgroup co-chairs Peter Perez, U.S. Deputy Assistant Secretary for Manufacturing and Xu Youjun, Director General of the China Department for International Cooperation, agreed to a 2012 work plan that includes a workshop to provide China with expert assistance in their transition to IEC 60601-1 third edition safety and performance standards later this year.
-
MITA Statement
The Medical Imaging & Technology Alliance (MITA) today commended an actuarial cost-benefit analysis conducted by Milliman, Inc. showing that low-dose spiral computed tomography (CT) of individuals at high risk for lung cancer would save thousands of lives at a relatively low cost if the procedure were routinely covered by commercial insurers.







